Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
Based on the Chinese SLE Treatment and Research group registry,[3] SLE patients who fulfill the 2012 Systemic Lupus International Collaborating Clinics classification criteria and with a Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) ≥2 were included from March 2016 to March 20...
Saved in:
Published in | Chinese medical journal Vol. 135; no. 18; pp. 2245 - 2247 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
China
Lippincott Williams & Wilkins
20.09.2022
Lippincott Williams & Wilkins Ovid Technologies Wolters Kluwer |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Based on the Chinese SLE Treatment and Research group registry,[3] SLE patients who fulfill the 2012 Systemic Lupus International Collaborating Clinics classification criteria and with a Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) ≥2 were included from March 2016 to March 2020 in Peking Union Medical College Hospital. According to the European consensus criteria, SLE remission was defined as a clinical SLEDAI-2K = 0 and PGA <0.5, with prednisolone (or equivalent) ≤5 mg daily. Pulmonary arterial hypertension (PAH) was defined as a resting mean pulmonary artery pressure >25 mmHg assessed by right heart catheterization, in the presence of normal pulmonary capillary wedge pressure <15 mmHg and pulmonary vascular resistance >3 Wood units, or a resting systolic pulmonary artery pressure >40 mmHg estimated by transthoracic echocardiography. According to our study, tacrolimus combined with or without vasodilator therapy might improve not only the SLEDAI-2K score but also the heart function of patients with SLE-PAH. |
---|---|
AbstractList | Based on the Chinese SLE Treatment and Research group registry,[3] SLE patients who fulfill the 2012 Systemic Lupus International Collaborating Clinics classification criteria and with a Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) ≥2 were included from March 2016 to March 2020 in Peking Union Medical College Hospital. According to the European consensus criteria, SLE remission was defined as a clinical SLEDAI-2K = 0 and PGA <0.5, with prednisolone (or equivalent) ≤5 mg daily. Pulmonary arterial hypertension (PAH) was defined as a resting mean pulmonary artery pressure >25 mmHg assessed by right heart catheterization, in the presence of normal pulmonary capillary wedge pressure <15 mmHg and pulmonary vascular resistance >3 Wood units, or a resting systolic pulmonary artery pressure >40 mmHg estimated by transthoracic echocardiography. According to our study, tacrolimus combined with or without vasodilator therapy might improve not only the SLEDAI-2K score but also the heart function of patients with SLE-PAH. |
Author | Tian, Xinping Li, Mengtao Zhang, Shangzhu Zeng, Xiaofeng Peng, Liying Wang, Qian Zhou, Shuang Zhao, Yan Zhao, Jiuliang Leng, Xiaomei Bai, Wei Wang, Yanhong |
AuthorAffiliation | Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China Department of Epidemiology and Bio-statistics (YW), Institute of Basic Medical Science, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100053, China |
AuthorAffiliation_xml | – name: Department of Epidemiology and Bio-statistics (YW), Institute of Basic Medical Science, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100053, China – name: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China |
Author_xml | – sequence: 1 givenname: Wei surname: Bai fullname: Bai, Wei organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 2 givenname: Mengtao surname: Li fullname: Li, Mengtao organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 3 givenname: Shuang surname: Zhou fullname: Zhou, Shuang organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 4 givenname: Liying surname: Peng fullname: Peng, Liying organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 5 givenname: Jiuliang surname: Zhao fullname: Zhao, Jiuliang organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 6 givenname: Xinping surname: Tian fullname: Tian, Xinping organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 7 givenname: Qian surname: Wang fullname: Wang, Qian organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 8 givenname: Xiaomei surname: Leng fullname: Leng, Xiaomei organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 9 givenname: Shangzhu surname: Zhang fullname: Zhang, Shangzhu organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 10 givenname: Yanhong surname: Wang fullname: Wang, Yanhong organization: Department of Epidemiology and Bio-statistics (YW), Institute of Basic Medical Science, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100053, China – sequence: 11 givenname: Yan surname: Zhao fullname: Zhao, Yan organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China – sequence: 12 givenname: Xiaofeng surname: Zeng fullname: Zeng, Xiaofeng organization: Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35946790$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkk1vEzEQhi1URNPCP0BoJS5ctvh77d5QxEelIi5wtma9XuLgXQfbS5R_j0NahHLCB49m9Mwrj9-5QhdznB1CLwm-IVh3b9ef9Q3-51CG6RO0ooLTVkhOLtAKMylbqbW-RFc5bysjRCefoUsmNJedxisU18HP3kJo3DjWaA9NHJsCNsXgpyU3fm7yIRc3eduEZVcrLh3Kxk1QYq7Z3pdN8wuSjzWZYPajywWKj3O-baBJDkK7jykMTS7LcHiOno4QsnvxEK_Rtw_vv64_tfdfPt6t3923lmvK2g4LOlLHCONsID2lRMrRdRxkryzulQMBVikuB9CcOSJ721mqBGbD6Kzq2TW6O-kOEbZml_wE6WAiePOnENN3A6l4G5xR_cAHIYmrN-cj6QfGFGBNtMJYAVStNyetXYo_lzqemXy2LgSYXZ3a0A5jyRSRuqKvz9BtXNJcJ62U4Jp0ojtSrx6opZ_c8Pd5j7ZU4PYEVBtyTm401p8-tSTwwRBsjjtg6g6Y8x2ozfys-VH__9r2MRSX8o-w7F0ym2pg2RxxqhnDLcWUYk0xbmuJMPYbKx7C5w |
CitedBy_id | crossref_primary_10_3390_jcm13041047 |
Cites_doi | 10.1183/13993003.02449-2016 10.1136/annrheumdis-2020-216924 10.1177/0961203313499086 10.1136/annrheumdis-2015-207726 10.1136/annrheumdis-2013-205139 |
ContentType | Journal Article |
Copyright | Lippincott Williams & Wilkins Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Lippincott Williams & Wilkins – notice: Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
DOI | 10.1097/CM9.0000000000002302 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2542-5641 |
EndPage | 2247 |
ExternalDocumentID | oai_doaj_org_article_8bd4d561e4d544f1bd338a09198008aa 35946790 10_1097_CM9_0000000000002302 00029330-202209200-00013 |
Genre | Letter Correspondence |
GroupedDBID | --- -05 -0E 0R~ 29B 2WC 40I 5GY 5RE 5VR 5VS 6J9 7X7 88E 8FI 8FJ 92F 92I 92M AAAAV AAHPQ AAIQE AASCR ABASU ABCQX ABDIG ABUWG ABVCZ ABZZY ACGFO ACGFS ACILI ACXJB ADGGA ADHPY ADPDF AENEX AFBFQ AFDTB AFKRA AHMBA AHQNM AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ ALIPV ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BENPR BPHCQ BQLVK BVXVI CCEZO CCPQU CHBEP CIEJG CW9 DIK DIWNM EBS EEVPB EJD F5P FA0 FCALG FRP FYUFA GNXGY GQDEL GROUPED_DOAJ GX1 HLJTE HMCUK HYE IAO IHR IKREB IPNFZ JUIAU KQ8 L7B M1P M48 OK1 OPUJH OVD OVDNE OVEED OXXIT P2P P6G PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RIG RLZ RNS RPM RT5 S.. T8U TCJ TEORI TGQ TR2 TSPGW U1F U5O UKHRP W2D WFFXF XSB AAYXX CITATION OVT 3V. ABXLX CGR CUY CVF ECM EIF NPM Q-- Q-4 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO |
ID | FETCH-LOGICAL-c4923-7052f2e31343d1b22166fe74a6b8c0b8ea5ac8846da943e16bc7c28503dfec8b3 |
IEDL.DBID | M48 |
ISSN | 0366-6999 2542-5641 |
IngestDate | Wed Aug 27 01:28:18 EDT 2025 Fri Jul 11 08:07:31 EDT 2025 Fri Jul 25 09:34:34 EDT 2025 Wed Feb 19 02:23:16 EST 2025 Thu Apr 24 23:07:37 EDT 2025 Thu Jul 03 08:10:52 EDT 2025 Fri May 16 03:50:38 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4923-7052f2e31343d1b22166fe74a6b8c0b8ea5ac8846da943e16bc7c28503dfec8b3 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1097/CM9.0000000000002302 |
PMID | 35946790 |
PQID | 2754917579 |
PQPubID | 2042885 |
PageCount | 3 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8bd4d561e4d544f1bd338a09198008aa proquest_miscellaneous_2700638169 proquest_journals_2754917579 pubmed_primary_35946790 crossref_citationtrail_10_1097_CM9_0000000000002302 crossref_primary_10_1097_CM9_0000000000002302 wolterskluwer_health_00029330-202209200-00013 |
PublicationCentury | 2000 |
PublicationDate | 2022-September-20 |
PublicationDateYYYYMMDD | 2022-09-20 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-September-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | China |
PublicationPlace_xml | – name: China – name: Baltimore |
PublicationTitle | Chinese medical journal |
PublicationTitleAlternate | Chin Med J (Engl) |
PublicationYear | 2022 |
Publisher | Lippincott Williams & Wilkins Lippincott Williams & Wilkins Ovid Technologies Wolters Kluwer |
Publisher_xml | – name: Lippincott Williams & Wilkins – name: Lippincott Williams & Wilkins Ovid Technologies – name: Wolters Kluwer |
References | Spiekerkoetter (R5-20250603) 2017; 50 van Vollenhoven (R1-20250603) 2014; 73 Franklyn (R4-20250603) 2016; 75 Fanouriakis (R2-20250603) 2020; 79 Li (R3-20250603) 2013; 22 |
References_xml | – volume: 50 start-page: 1602449 year: 2017 ident: R5-20250603 article-title: Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension publication-title: Eur Respir J doi: 10.1183/13993003.02449-2016 – volume: 79 start-page: 713 year: 2020 ident: R2-20250603 article-title: 2019 update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2020-216924 – volume: 22 start-page: 1192 year: 2013 ident: R3-20250603 article-title: Chinese SLE treatment and research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus publication-title: Lupus doi: 10.1177/0961203313499086 – volume: 75 start-page: 1615 year: 2016 ident: R4-20250603 article-title: Definition and initial validation of a Lupus Low Disease Activity State (LLDAS) publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2015-207726 – volume: 73 start-page: 958 year: 2014 ident: R1-20250603 article-title: Treat-to-target in systemic lupus erythematosus: recommendations from an international task force publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-205139 |
SSID | ssj0025576 |
Score | 2.3157163 |
Snippet | Based on the Chinese SLE Treatment and Research group registry,[3] SLE patients who fulfill the 2012 Systemic Lupus International Collaborating Clinics... |
SourceID | doaj proquest pubmed crossref wolterskluwer |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2245 |
SubjectTerms | Arthritis Cardiac catheterization Humans Hypertension Immunosuppressive agents Immunosuppressive Agents - therapeutic use Intubation Lupus Lupus Erythematosus, Systemic - drug therapy Proteins Pulmonary arteries Remission (Medicine) Tacrolimus - therapeutic use Thrombocytopenia Treatment Outcome |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlh9JSSr-zSVpU6FXE-rSVWxIaQmF7aiA3I8kShG7tEO-25N93xpKXJBRyqQ8G2bKxNSPPGz_piZAvStXCW4cMq5JMdY1mDnJs1gUrY-KuShonCi-_m_ML9e1SX95Z6gvHhGV54Nxwh43vVAdBPsJeqcR9B0mVgyhnAeo0boJGUJqTqZJqaV0XltIwAxhonjRn68PTpc2ihWUDDC7uBaVJu_9fgPM5efFnQA57_DkNYb8TiM5ekZcFQdLj_OSvyZPYvyFPl4Ujf0uGIvW5ohHlIVy4pUOiaxdwfZ5fm5Fe9TTrN18Futpcw5F4c5vFW4cRSvhrlv6GHHqAAspjpDhmwn48oo4CylyxSWiVTtq078jF2dcfp-esLKvAAqqxsbrSIokouVSy414IbkyKtXLGN6HyTXTahQZwSeeskpEbH-ogGl3JLsXQePme7PRDH3cJFdyhYJkzMigVUu2FEU7xEFQ0VayqBZFzu7ahaI7j0herdua-wRrtQ2ssCNtedZ01Nx6pf4Im29ZFxezpAPhRW_yofcyPFuRgNnhbuvHYihrSZwBYtV2Qz9vT0AGRVXF9BDu0yNwbpF-hzofsKNsnkdpCILLQDuye57R5kiu-icA_SvCtEuDFIs_y53Lvf7zRPnmGt8XBLaI6IDvrm038CAhq7T9NneUvIH8Qgw priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1di9QwFA26giiy-LmOrhLB17BtkiaNL6KLyyKMTy7MW0nSRBbHdnY6o-y_994mnXVl0T4U0iaQ9ubj3JzkXELeSqm5MxYZVimYbOuKWfCxWeuNCLG0RazwoPD8izo9k58X1SIvuA15W-U0Jo4Dddt7XCM_4ho8GZjrtHm_umAYNQrZ1RxC4za5g9Jl2Kr14srhqiqduUrFFCCh6eic0UfHc5OkC_MFSJxfm5pGBf-bYOd98uBXj0z28H3cyP7HdHTykOxnHEk_JMM_IrdC95jcnWem_Anps-DnkgYUibD-kvaRbqzHKD0_tgM972hScT73dLldwZOwvkwSrv0AKVygpT_Bk-4hgSIZMQyJth_eUUsBay7ZKLdKR4Xap-Ts5NPX41OWgyswj5psTBcVjzyIUkjRlo7zUqkYtLTK1b5wdbCV9TWgk9YaKUKpnNee11Uh2hh87cQzstf1XXhOKC8typZZJbyUPmrHFbey9F4GVYSimBEx_dfGZ-VxDICxbCYGHKzR_G2NGWG7UqukvPGf_B_RZLu8qJs9PujX35rcDZvatbIFyBjgLmUsXQsuugXMZAA419bOyOFk8CZ35qG5anoz8mb3Grohciu2C2CHBvl7hSQs5DlIDWVXE1EZmI4M_Ad2reU06agrfgnHdSUYsTgvDE9n_Uvx4t-VeUnuYQHcvMKLQ7K3WW_DK0BIG_d67Aa_AW4BCHU priority: 102 providerName: ProQuest |
Title | Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00029330-202209200-00013 https://www.ncbi.nlm.nih.gov/pubmed/35946790 https://www.proquest.com/docview/2754917579 https://www.proquest.com/docview/2700638169 https://doaj.org/article/8bd4d561e4d544f1bd338a09198008aa |
Volume | 135 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ta9UwFA5zA1FEfN_VeYng10jz0qQdyNjG5hDuEPHC_VaSNJVhbbfbe9X773dO33AyEfsh0DYNbU5enpOneQ4hb5UywqUWGVYlmcqTmFnwsVnuUxkKbqMixo3Cs3N9NlcfF_FiiwwxW_sKbG517TCe1HxZvvt1tTmADv9-EGA8nqWdDGF_AKqGQXkH5iaDMQ1mauQVAD-bnr3UTAM2GjbT_aWUG5NVq-l_GxC9Tx78rJHbbr61v7b_NkGdPiIPe2RJD7um8JhsheoJuTvrufOnpO4lQEsaUDbC-g2tC7qyHuP2fF839KKina7zhafl-hKuhOWmE3WtGzjDJVv6A3zrGk5QNqMITUfkN_vUUkCfJWsFWGmrWfuMzE9PvhyfsT7cAvOo0sZMFItCBMmlkjl3QnCti2CU1S7xkUuCja1PAK_kNlUycO288SKJI5kXwSdOPifbVV2FXUIFtyhkZrX0SvnCOKGFVdx7FXQUomhC5FCvme-1yDEkRpkNnDhYI_vTGhPCxqcuOy2Of-Q_QpONeVFJu71QL79mfcfMEperHEBkgFSpgrscnHYLKCoFKJ1YOyF7g8GzoXVmwoBbDcDLpBPyZrwNHRPZFlsFsEOGjL5GWhbyvOgayvgmMk5hgkqhHtiNlpN1m1_xSwSuNMEYJkSUim73P5cv_7MGXpF7WAL-3yKiPbK9Wq7DawBRKzcld8zCTMnO0cn5p8_TdikC0g8LPm17zDVUTBPB |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIfEhhPgYUBhgJHi05tiOkyAhBIOpY-ueNqlvxnEcNFGa0rRM_af4G7nLR8cQgqf1oVISJ0p8Z9_vfOffAbzUOpF55ijCqhXXRRpzhz42L3ymQhk5Uca0UXh0ZIYn-tM4Hm_Az34vDKVV9nNiM1EXlac18h2ZoCeDti7J3s6-c6oaRdHVvoRGqxYHYXWGLlv9Zv8DyveVlHsfj3eHvKsqwD2RkfFExLKUQUVKqyLKpYyMKUOinclTL_I0uNj5FM1y4TKtQmRyn3iZxkIVZfBprvC5V-AqGl5Bzl4yPnfw4jjpYqOGG0Re_Va9LNnZHWUtVWL3Q-QvL5jCpmLA32DuTbh1VlHkvP7aJM7_Zv727sDtDreyd62i3YWNML0H10ZdZP4-VB3B6IQFIqVwfsWqki2cp6pA35Y1O52yljX61LPJcoZnwnzVUsZWNR7RgjD7gZ57hQdEylGGuk0TqF8zxxDbTnhD78oaRtwtOLmUbn8Am9NqGh4Bk5EjmjRnlNfal0kujXQ68l4HI4IQA1B9v1rfMZ1TwY2J7SPuKA37pzQGwNd3zVqmj_-0f08iW7clnu7mRDX_Yrthb9O80AVC1ID_WpdRXiiVOsRoGQL11LkBbPcCt93kUdtzVR_Ai_VlHPYUy3HTgHKwlC9gKOiLbR62irJ-ExVnaP4y7Ad-QXNsu7WWvkTSOhbOkFKKTLbcApF6_O-XeQ7Xh8ejQ3u4f3TwBG7QzZQ4I8U2bC7my_AU0dkif9YMCQafL3sM_gKxfkTm |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJ00ghPimMMBIkLegxHYcBykPox_sg3aTtsF4Co7joInSVE27qf89d_moGAIhHtaHtkmcKvXZ59_57n5HyGshQpZGGj2sgrsiU4GrwcZ2MxNxm_vaywNMFB6N5e6p2D8LzjZIW6wBk8_K2Vv8qNQ0fsFyOGgXnsT7x07vuBd_ccaDz8fx2Dna-TCotqkxSMI56g_jldOPi4t84fQP45afsTeKapbC5gWgmzWZHwd2dQk2Xhnv9WFAvGFsODjp7bpNGQLXIHuZG3oBy5nlPhc881PGfClzGwotU2W8VFkdaKNgHc90JLj1ZWpCw1Tg8Sy3RqUcfvcG2VQKLIcO2Tz8NBj01zZhEISNO1W6EsBam933l-e-snpWRQb-hIxvkduXBTrby-9VrP0vK-bwLrnTQF26U4_Ne2TDTu-TrVHjzH9AioaTdEIt8lhos6JFThfaYCGhH8uSnk9pTTR9buhkOYMzdr6qWWaLEo5wD5legLFfwAHyeOS2rCMLyndUU4DDE7dihKUVie5DcnotHf-IdKbF1D4hlPkamdW05EYIk4cpk0wL3xhhpWc9r0t426-JacjRsUbHJGmd9CCN5HdpdIm7vmtWk4P8o_17FNm6LVJ7VyeK-bek0RSJSjORAaq18C5E7qcZ50oDrIsA2yutu2S7FXjS6JsyYSHY-YAEw6hLXq0vg6ZA94-eWpBDgiEGEv3E0OZxPVDWT8KDCFbMCPrBvTJykjobF_8Jw60vUKqMeRGr6Qh8_vQ_278kWzBNk49744Nn5CZexNgb5m2TzmK-tM8B4C3SF80koeTrdc_Ln5hCVOo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+efficacy+of+tacrolimus+in+systemic+lupus+erythematosus+with+various+manifestations%3A+a+real-world+study&rft.jtitle=Chinese+medical+journal&rft.au=Bai%2C+Wei&rft.au=Li%2C+Mengtao&rft.au=Zhou%2C+Shuang&rft.au=Peng%2C+Liying&rft.date=2022-09-20&rft.issn=0366-6999&rft.eissn=2542-5641&rft.volume=135&rft.issue=18&rft.spage=2245&rft.epage=2247&rft_id=info:doi/10.1097%2FCM9.0000000000002302&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_CM9_0000000000002302 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0366-6999&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0366-6999&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0366-6999&client=summon |